Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Ochirbat Batbayar"'
Autor:
Batmunkh, Tsetsegsaikhan, Moore, Kerryn A., Thomson, Helen, Altangerel, Bolor, Amraa, Otgonjargal, Avaa, Naranbaatar, Batbayar, Lkhagvagaram, Batsukh, Khishigjargal, Bright, Kathryn, Burentogtokh, Tsogjargal, Ha Do, Lien Anh, Dorj, Gantuya, Hart, John D., Javkhlantugs, Khulan, Jigjidsuren, Sarantsetseg, Justice, Frances, Li, Shuo, Licciardi, Paul V., Mashbaatar, Khaliunaa, Mazarakis, Nadia, Neal, Eleanor F.G., Nguyen, Cattram Duong, Ochirbat, Batbayar, Tsolmon, Bilegtsaikhan, Tuya, Alimaa, Surenjav, Unursaikhan, von Mollendorf, Claire, Mulholland, Kim
Publikováno v:
In The Lancet Regional Health - Western Pacific January 2024 42
Autor:
Ganmaa, Davaasambuu *, Khudyakov, Polyna, Buyanjargal, Uyanga, Tserenkhuu, Enkhtsetseg, Erdenenbaatar, Sumiya, Achtai, Chuluun-Erdene, Yansanjav, Narankhuu, Delgererekh, Baigal, Ankhbat, Munkhzaya, Tsendjav, Enkhjargal, Ochirbat, Batbayar, Jargalsaikhan, Badamtsetseg, Enkhmaa, Davaasambuu, Martineau, Adrian R **
Publikováno v:
In The Lancet Diabetes & Endocrinology January 2024 12(1):29-38
Autor:
Ganmaa, Davaasambuu, Khudyakov, Polyna, Buyanjargal, Uyanga, Jargalsaikhan, Badamtsetseg, Baigal, Delgerekh, Munkhjargal, Oyunsuren, Yansan, Narankhuu, Bolormaa, Sunjidmaa, Lkhagvasuren, Enkhsaikhan, Sempos, Christopher T., Bromage, Sabri, Wu, Zhenqiang, Ochirbat, Batbayar, Gunchin, Batbaatar, Martineau, Adrian R.
Publikováno v:
Clinical Infectious Diseases, 2019 Sep 01. 69(5), 813-819.
Externí odkaz:
https://www.jstor.org/stable/26748686
Publikováno v:
Breathe, Vol 14, Iss 3, Pp 180-183 (2018)
Externí odkaz:
https://doaj.org/article/20ccd6e826524fe2abfc04009f95bca0
Autor:
Claudia C. Dobler, Sarah Korver, Ochirbat Batbayar, Batiargal Nyamdulam, Sodnomdarjaa Oyuntsetseg, Bold Tsolmon, Bazarragchaa Surmaajav, Byambaa Bayarjargal, Ben J. Marais
Publikováno v:
Emerging Infectious Diseases, Vol 21, Iss 8, Pp 1451-1454 (2015)
In Ulaanbaatar, Mongolia, multidrug-resistant tuberculosis (MDR TB) was diagnosed for more than a third of new sputum smear–positive tuberculosis patients for whom treatment had failed. This finding suggests a significant risk for community-acquire
Externí odkaz:
https://doaj.org/article/54f99ff0773f4479b046ee5964af5272
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jadambaa Tsolmo, Jutmaan Yanjmaa, Murneren Tunsag, Davaasambuu Ganmaa, Saranjav Ariunzaya, Polyna Khudyakov, Tserenkhuu Enkhtsetseg, Erdenebaatar Sumiya, Dorjnamjil Khulan, Garmaa Gantsetseg, Buyanjargal Uyanga, Ben J. Marais, Ankhbat Munkhzaya, Davaasambuu Enkhmaa, Donna Spiegelman, Baigali Delgerekh, Batbileg Bolortuya, James A Seddon, Ochirbat Batbayar, Bazarsaikhan Amarsaikhan, Adrian R. Martineau, Ganbaatar Erdenetuya, Xin Zhou
Publikováno v:
N Engl J Med
BACKGROUND: Vitamin D metabolites support innate immune responses to Mycobacterium tuberculosis. Data from phase 3, randomized, controlled trials of vitamin D supplementation to prevent tuberculosis infection are lacking. METHODS: We randomly assigne
Publikováno v:
Breathe
Breathe, Vol 14, Iss 3, Pp 180-183 (2018)
Breathe, Vol 14, Iss 3, Pp 180-183 (2018)
The challenges of tuberculosis (TB) control vary significantly between countries with a low and high incidence of TB. A major focus of TB control efforts in countries with a low incidence of TB is on treatment of latent TB infection in high-risk grou
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
B. Solongo, B. Tsolmon, Sarah Korver, S. Oyuntsetseg, Ben J. Marais, Ochirbat Batbayar, Cameron M. Wright, Claudia C. Dobler
Publikováno v:
The International Journal of Tuberculosis and Lung Disease. 19:657-662
BACKGROUND Many countries restrict access to directly observed therapy (DOT) for tuberculosis (TB) to government health facilities. More innovative approaches are required to reduce non-adherence, improve patient outcomes and limit the risk of select